Efficacy and safety of high doses of safinamide in advanced Parkinson disease.

导出 LinkOut

翻译打印收藏纠错

作者： Fernando,Rodríguez-Jorge ^[1] ; Álvaro,Beltrán-Corbellini ^[2] ; J L,Chico-García ^[2] ; Paloma,Parra-Díaz ^[2] ; Belén,Baena-Álvarez ^[2] ; Javier,Pagonabarraga ^[3] ; Paula,Pérez-Torre ^[2] ; Isabel,Pareés ^[2] ; J L,López-Sendón ^[2] ; J C,Martínez-Castrillo ^[2] ; Araceli,Alonso-Cánovas ^[2]

作者单位： Movement Disorders Unit. Neurology Department, University Hospital Ramón y Cajal, Madrid, Spain. Electronic address: frjorge@salud.madrid.org. ^[1] Movement Disorders Unit. Neurology Department, University Hospital Ramón y Cajal, Madrid, Spain. ^[2] Movement Disorders Unit. Neurology Department, University Hospital Santa Creu i Sant Pau, Barcelona, Spain. ^[3]

关键词 Clinical global impression of improvement Dyskinesia Fluctuating Safinamide UPDRS IV

主题词丙氨酸(Alanine);抗震颤麻痹药(Antiparkinson Agents);苄胺类(Benzylamines);人类(Humans);左旋多巴(Levodopa);帕金森病(Parkinson Disease)

DOI 10.1016/j.parkreldis.2022.03.010

PMID 35344893

发布时间 2022-05-19

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交